Hideo Ueki
Overview
Explore the profile of Hideo Ueki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin W, Xue R, Ueki H, Huang P
Curr Cancer Drug Targets
. 2024 Apr;
25(3):244-256.
PMID: 38616744
Background: It remains controversial whether the current subtypes of kidney renal papillary cell carcinoma (KIRP) can be used to predict the prognosis independently. Objective: This observational study aimed to identify...
2.
Matsumoto J, Nishimoto A, Watari S, Ueki H, Shiromizu S, Iwata N, et al.
Mol Cell Biochem
. 2022 Dec;
478(8):1779-1790.
PMID: 36571650
UDP-glucuronosyltransferase (UGT) metabolizes a number of endogenous and exogenous substrates. Renal cells express high amounts of UGT; however, the significance of UGT in patients with renal cell carcinoma (RCC) remains...
3.
Lin W, Chen W, Zhong J, Ueki H, Xu A, Watanabe M, et al.
J Cancer
. 2022 Mar;
13(4):1214-1228.
PMID: 35281853
The interplay of inflammation and immunity affects all stages from tumorigenesis to progression, and even tumor response to therapy. A growing interest has been attracted from the biological function of...
4.
Sun J, Lin W, Li C, Ueki H, Xue R, Sadahira T, et al.
Am J Cancer Res
. 2021 Oct;
11(9):4528-4540.
PMID: 34659903
Posaconazole (POS) is a novel antifungal agent, which has been repurposed as an anti-tumor drug for its potential inhibition of Hedgehog signaling pathway. Hedgehog pathway is reported to be abnormally...
5.
Matsumoto J, Kotera Y, Watari S, Takeuchi K, Ueki H, Koyama T, et al.
Anticancer Res
. 2021 May;
41(5):2511-2521.
PMID: 33952479
Background/aim: This study aimed to elucidate the detailed characteristics of CYP3A5 expression and the association between CYP3A5 expression and clinical outcomes in patients with renal cell carcinoma (RCC). Patients And...
6.
Iwata T, Sadahira T, Ochiai K, Ueki H, Sasaki T, Haung P, et al.
Exp Ther Med
. 2020 Aug;
20(2):1739-1745.
PMID: 32765682
REIC/Dkk-3 is a tumor suppressor, and its expression is significantly downregulated in a variety of human cancer types. A previous study performed yeast two-hybrid screening and identified the small glutamine-rich...
7.
Tsugata T, Nikoh N, Kin T, Miyagi-Shiohira C, Nakashima Y, Saitoh I, et al.
Cell Med
. 2020 Jul;
10:2155179017733177.
PMID: 32634182
The low efficiency of in vitro differentiation of human embryonic stem cells (hESCs) or human-induced pluripotent stem cells (iPSCs) into insulin-producing cells is a crucial hurdle for the clinical implementation...
8.
Xu N, Li X, Watanabe M, Ueki H, Hu H, Li N, et al.
Am J Cancer Res
. 2018 Sep;
8(8):1624-1632.
PMID: 30210930
Cancer stem cells (CSCs) that closely correlated with tumor growth, metastasis, provide a plausible explanation for chemoresistance and cancer relapse. CSCs are usually isolated and enriched from carcinoma cells, which...
9.
Sakaguchi M, Sadahira T, Ueki H, Kinoshita R, Murata H, Yamamoto K, et al.
Oncol Rep
. 2017 Jun;
38(2):1108-1114.
PMID: 28627633
We developed and validated a novel hTERT/CMV promoter element-driven gene expression cassette that can robustly enhance cancer-specific gene expression. The following gene expressional elements were located in tandem within the...
10.
Mori A, Watanabe M, Sadahira T, Kobayashi Y, Ariyoshi Y, Ueki H, et al.
Acta Med Okayama
. 2017 Apr;
71(2):135-142.
PMID: 28420895
The cluster of differentiation 147 (CD147), also known as EMMPRIN, is a key molecule that promotes cancer progression. We previously developed an adenoviral vector encoding a tumor suppressor REIC/Dkk-3 gene...